Pierre-Olivier Bridevaux

Professeur titualaire

Université de Genève

Switzerland

Research Interests

Explore related searches

Professors in Switzerland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professeur titualaire at Université de Genève, Pierre-Olivier Bridevaux specializes in respiratory health, with a focus on asthma and COPD management. His recent research includes studies on corticosteroid use in severe asthma, the impact of comorbidities on asthma-related outcomes, and the long-term pulmonary recovery post-COVID-19. He is actively engaged in various observational studies and analyses related to respiratory diseases, contributing to the understanding of treatment adherence and the effects of COVID-19 on lung health.

Articles (15)

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (8)

Sebastian Robert Ott

Head of Departmebnt

St. Claraspital

SWITZERLAND

View details

Yok-Ai Que

SWITZERLAND

View details

Eric VAN GANSE

Self-Management Training Unit, Head

Hospices Civils de Lyon

FRANCE

View details

Martin Brutsche

Prof.

Kantonsspital St. Gallen

SWITZERLAND

View details

Christophe von Garnier

Head

Lausanne University Hospital

SWITZERLAND

View details

Jörg D. Leuppi

SWITZERLAND

View details

Sabina A. Guler

SWITZERLAND

View details

Marco Mancinetti

University of Fribourg

SWITZERLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Pierre-Olivier Bridevaux

Research Interests

Explore related searches

Contact this professor

About

Articles (15)

Substantial reduction in oral corticosteroid use after biologics initiation in severe asthma: An analysis based on Swiss pharmacy data

The Effect of Comorbidities on Asthma-Related Outcomes Over a Two-Year Period: A Prospective Analysis of Swiss Severe Asthma Registry (SSAR)

Early and Sustained Response to Benralizumab in Severe, Eosinophilic Asthma: A Real-World Observational Study

Pulmonary Recovery 12 Months after Non-Severe and Severe COVID-19: The Prospective Swiss COVID-19 Lung Study

Dysfunctional breathing symptoms, functional impact and quality of life in patients with long COVID-19: a prospective case series

Adherence to the GOLD Guidelines in Primary Care: Data from the Swiss COPD Cohort

Risk Factors for Recurrent Exacerbations in the General-Practitioner-Based Swiss Chronic Obstructive Pulmonary Disease (COPD) Cohort

CPET evidence of dysfunctional breathing after SARS-CoV2 in patients with persistent dyspnea

Comparison of COVID-19 mortality at the first and second wave adjusted for the 4C mortality score

Impact of COVID-19 on Clinical Frailty Scale - a multicentre prospective cohort study

Nomogram for patients with exacerbation in the general practitioners based Swiss chronic obstructive pulmonary disease cohort

Pulmonary function and radiological features 4 months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study

Swiss Recommendations for the Follow-Up and Treatment of Pulmonary Long COVID

Swiss Severe Asthma Registry (SSAR)-Good asthma control and high number of exacerbations. How does this fit?

Oral corticosteroid prescription in asthma: Swiss situation

Collaborators (8)

Sebastian Robert Ott

Yok-Ai Que

Eric VAN GANSE

Martin Brutsche

Christophe von Garnier

Jörg D. Leuppi

Sabina A. Guler

Marco Mancinetti

Make your next move.